id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OAR-2004-0074-0222,EPA,EPA-HQ-OAR-2004-0074,The Hamner Institute for Health Sciences Presentation on use of Physiologically-based pharmacokinetic (PBPK) modeling to reduce uncertainty in risk assessment: Example of manganese.,Supporting & Related Material,Report,2010-10-01T04:00:00Z,2010,10,,,2010-10-01T16:39:08Z,,0,0,0900006480b6489c